Research Paper Volume 14, Issue 24 pp 10171—10216
The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker
Figure 4. The signature genes differentiating TME subtypes. (A) Gene expression of signature A, B and TBC1D3G in three TME subtypes and normal samples. (B) The Venn diagram of signature A, B and PanImmune gene sets. (C) The enrichment of signature A and B in immune related gene sets. (D) The bubble diagram of signature A enriched in GO terms. (E) The GSEA plot of signature A enriched in cancer hallmark gene sets.